Concepedia

Vaccine adjuvants CpG (oligodeoxynucleotides ODNs), MPL (3-O-deacylated monophosphoryl lipid A) and naloxone-enhanced Th1 immune response to the Plasmodium vivax recombinant thrombospondin-related adhesive protein (TRAP) in mice

Saeed Nazeri, Sedigheh Zakeri, Akram Abouie Mehrizi, Navid D. Djadid, Georges Snounou, Chiara Andolina, François Nosten

Medical Microbiology and Immunology · 2018 · 12 citations · 52 references

DOI

Concepts

References

52

A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine against<i>Plasmodium falciparum</i><i>Malaria</i>

José A. Stoute, M. Slaoui, D. Gray Heppner et al. · New England Journal of Medicine · 1997 · 879 citations · Full text

, , +17

Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells

Anne Krug, Simon Rothenfußer, Veit Hornung et al. · European Journal of Immunology · 2001 · 875 citations · Full text

, , +17

Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA

Zuhair K. Ballas, Wendy Rasmussen, A M Krieg · The Journal of Immunology · 1996 · 755 citations · Full text

, , +15

New horizons in adjuvants for vaccine development

Steven G. Reed, Sylvie Bertholet, Rhea N. Coler et al. · Trends in Immunology · 2008 · 613 citations

, , +13

Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection

Kent E. Kester, James F. Cummings, Opokua Ofori‐Anyinam et al. · The Journal of Infectious Diseases · 2009 · 538 citations · Full text

, , +17